Mischa T Rijnierse Selected Research

Implantable Defibrillators (Implantable Cardioverter-Defibrillator)

1/2023	Cardiac Magnetic Resonance Imaging-Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter-Defibrillator.
1/2022	Recurrent ventricular arrhythmias and mortality in cardiac arrest survivors with a reversible cause with and without an implantable cardioverter defibrillator: A systematic review.
1/2021	Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
1/2019	The Benefit of Prophylactic Implantable Cardioverter Defibrillator Implantation in Asymptomatic Heart Failure Patients With a Reduced Ejection Fraction.
7/2017	Usefulness of Left Atrial Emptying Fraction to Predict Ventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillators.
4/2016	Principles and techniques of imaging in identifying the substrate of ventricular arrhythmia.
1/2016	Non-invasive imaging to identify susceptibility for ventricular arrhythmias in ischaemic left ventricular dysfunction.
1/2014	Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mischa T Rijnierse Research Topics

Disease

6	Cicatrix (Scar) 01/2021 - 01/2016
5	Cardiomyopathies (Cardiomyopathy) 07/2017 - 01/2014
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 07/2015
2	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2021
1	Atrial Fibrillation 01/2023
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2022
1	Takotsubo Cardiomyopathy 01/2022
1	Myocardial Infarction 01/2022
1	Bundle-Branch Block (Fascicular Block) 10/2021
1	Ischemia 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Pulmonary Arterial Hypertension 04/2020
1	Pathologic Constriction (Stenosis) 01/2019
1	Heart Failure 01/2019
1	Hyperemia 01/2019
1	Heart Diseases (Heart Disease) 01/2016
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2015

Drug/Important Bio-Agent (IBA)

5	GadoliniumIBA 01/2021 - 01/2016
1	Bisoprolol (Concor)FDA LinkGeneric 04/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	Everolimus FDA Link 01/2019
1	CreatinineIBA 07/2017
1	Deoxycytidine Monophosphate (DCMP)IBA 07/2015

Therapy/Procedure

8	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2023 - 01/2014
6	Therapeutics 01/2022 - 04/2016
4	Sympathectomy (Sympathectomies) 01/2020 - 07/2015
2	Secondary Prevention 10/2021 - 01/2021
1	Drug-Eluting Stents 01/2019
1	Denervation 12/2016